AstraZeneca PLC (AZN)

AstraZeneca PLC (AZN $68.79)
- $68.79 Fwd P/E: 30.88X Cap: $214.78B
- View AZN Profile
- View Questions on AZN

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Alibaba Group Holding Limited American Depositary Shares each representing eight (BABA $120.23)
- $120.23 Fwd P/E: 16.08X Cap: $277.64B
- View BABA Profile
- View Questions on BABA
Baidu Inc. (BIDU $87.81)
- $87.81 Fwd P/E: 9.55X Cap: $30.18B
- View BIDU Profile
- View Questions on BIDU
Novo Nordisk A/S (NVO $64.31)
- $64.31 Fwd P/E: 18.14X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Tencent Holdings Ltd. ADR (TCEHY $66.03)
- $66.03 Fwd P/E: 29.41X Cap: $615.46B
- View TCEHY Profile
- View Questions on TCEHY
Novartis AG (NVS $114.25)
- $114.25 Fwd P/E: 19.46X Cap: $225.65B
- View NVS Profile
- View Questions on NVS
GSK plc American Depositary Shares (Each representing two) (GSK $36.31)
- $36.31 Fwd P/E: 21.74X Cap: $77.53B
- View GSK Profile
- View Questions on GSK
JD.com Inc. (JD $33.92)
- $33.92 Fwd P/E: 9.05X Cap: $49.29B
- View JD Profile
- View Questions on JD
AstraZeneca PLC (AZN $68.79)
- $68.79 Fwd P/E: 30.88X Cap: $214.78B
- View AZN Profile
- View Questions on AZN
ASML Holding N.V. (ASML $734.58)
- $734.58 Fwd P/E: 32.65X Cap: $288.89B
- View ASML Profile
- View Questions on ASML
SAP SE ADS (SAP $305.97)
- $305.97 Fwd P/E: 98.74X Cap: $375.88B
- View SAP Profile
- View Questions on SAP
PDD Holdings Inc. (PDD $109.00)
- $109.00 Fwd P/E: 10.28X Cap: $154.74B
- View PDD Profile
- View Questions on PDD
Lvmh Moet Hennessy Louis Vuitton SE ADR - Level I (LVMUY $109.72)
- $109.72 Cap: $275.43B
- View LVMUY Profile
- View Questions on LVMUY

Q: Good morning, I am looking for an alternative to big American tech. Hopefully in Europe or perhaps Asia. When large Canadian pension plans are moving away from US investments, I think this is worth exploring. Would appreciate your thoughts.

Read Answer Asked by Joanne on April 17, 2025

Amazon.com Inc. (AMZN $226.13)
- $226.13 Fwd P/E: 36.83X Cap: $2.40T
- View AMZN Profile
- View Questions on AMZN
Costco Wholesale Corporation (COST $950.95)
- $950.95 Fwd P/E: 55.55X Cap: $421.72B
- View COST Profile
- View Questions on COST
Dollarama Inc. (DOL $187.74)
- $187.74 Fwd P/E: 42.86X Cap: $52.04B
- View DOL Profile
- View Questions on DOL
Metro Inc. (MRU $105.10)
- $105.10 Fwd P/E: 23.62X Cap: $23.06B
- View MRU Profile
- View Questions on MRU
North West Company Inc. (The) (NWC $47.65)
- $47.65 Fwd P/E: 16.9X Cap: $2.27B
- View NWC Profile
- View Questions on NWC
- View Reports on NWC
AstraZeneca PLC (AZN $68.79)
- $68.79 Fwd P/E: 30.88X Cap: $214.78B
- View AZN Profile
- View Questions on AZN

Q: Amazon's decision to close operations in Quebec and lay off workers disappoints me. I wish to sell it and find some alternatives. I already own Costco. Coincidentally Astrazeneca announced Canadian expansion plans. What do you think of their stock?

Read Answer Asked by Alex on January 28, 2025

Amgen Inc. (AMGN $294.76)
- $294.76 Fwd P/E: 26.87X Cap: $158.49B
- View AMGN Profile
- View Questions on AMGN
Abbott Laboratories (ABT $123.67)
- $123.67 Fwd P/E: 16.06X Cap: $215.16B
- View ABT Profile
- View Questions on ABT
Pfizer Inc. (PFE $24.47)
- $24.47 Fwd P/E: 17.73X Cap: $139.12B
- View PFE Profile
- View Questions on PFE
AstraZeneca PLC (AZN $68.79)
- $68.79 Fwd P/E: 30.88X Cap: $214.78B
- View AZN Profile
- View Questions on AZN
Viking Therapeutics Inc. (VKTX $32.01)
- $32.01 Cap: $3.44B
- View VKTX Profile
- View Questions on VKTX

Q: Aside from LLY and NVO, what other healthcare companies might enjoy success with weight loss drugs or products related to them? I’ve heard good things about ABT., AMGN, PFE, AZN, RHHBY and others in this regard, but I was wondering how you might rank them and/or others (most promising names first). I’m quite interested in Roche which has been showing strength after a long period of weakness (it’s now $35.69 as of Friday July 12).

Read Answer Asked by Brian on July 16, 2024